These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 28757451)

  • 1. Six years' experience of tolerance induction in renal transplantation using stem cell therapy.
    Vanikar AV; Trivedi HL; Thakkar UG
    Clin Immunol; 2018 Feb; 187():10-14. PubMed ID: 28757451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Co-infusion of donor adipose tissue-derived mesenchymal and hematopoietic stem cells helps safe minimization of immunosuppression in renal transplantation - single center experience.
    Vanikar AV; Trivedi HL; Kumar A; Gopal SC; Patel HV; Gumber MR; Kute VB; Shah PR; Dave SD
    Ren Fail; 2014 Oct; 36(9):1376-84. PubMed ID: 25246338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stem cells versus donor specific transfusions for tolerance induction in living donor renal transplantation: a single-center experience.
    Dave SD; Vanikar A; Trivedi HL; Gumber MR; Patel HV; Shah PR; Kute VB
    Transplantation; 2013 Jan; 95(1):155-60. PubMed ID: 23263505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pre-transplant co-infusion of donor-adipose tissue derived mesenchymal stem cells and hematopoietic stem cells may help in achieving tolerance in living donor renal transplantation.
    Vanikar AV; Trivedi HL; Gopal SC; Kumar A; Dave SD
    Ren Fail; 2014 Apr; 36(3):457-60. PubMed ID: 24344734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of co-transplantation of mesenchymal stem cells and hematopoietic stem cells as compared to hematopoietic stem cell transplantation alone in renal transplantation to achieve donor hypo-responsiveness.
    Vanikar AV; Trivedi HL; Feroze A; Kanodia KV; Dave SD; Shah PR
    Int Urol Nephrol; 2011 Mar; 43(1):225-32. PubMed ID: 20084457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abrogation of antibodies improves outcome of renal transplantation.
    Trivedi HL; Vanikar AV; Gumber MR; Patel HV; Shah PR; Kute VB
    Transplant Proc; 2012 Jan; 44(1):241-7. PubMed ID: 22310623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stem cell transplantation in living donor renal transplantation for minimization of immunosuppression.
    Vanikar AV; Trivedi HL
    Transplantation; 2012 Oct; 94(8):845-50. PubMed ID: 22992765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Desensitization Protocol in Recipients of Deceased Kidney Donor With Donor-Specific Antibody-Low Titers.
    Kanter Berga J; Sancho Calabuig A; Gavela Martinez E; Puig Alcaraz N; Avila Bernabeu A; Crespo Albiach J; Molina Vila P; Beltrán Catalan S; Pallardó Mateu L
    Transplant Proc; 2016 Nov; 48(9):2880-2883. PubMed ID: 27932097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of Mixed Lymphocyte Reaction Assay to Evaluate Immune Tolerance before Kidney Transplantation with an Immunosuppression-Free Protocol following Hematopoietic Stem Cell Transplantation from the Same Donor.
    Nonoyama S; Hotta K; Iwahara N; Tanabe T; Hirose T; Harada S; Junichi S; Nakazawa D; Shigematsu A; Otsuka T; Shinohara N
    Nephron; 2023; 147(10):621-626. PubMed ID: 37231903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mesenchymal stem cells enhance the induction of mixed chimerism and tolerance to rat hind-limb allografts after bone marrow transplantation.
    Pan H; Zhao K; Wang L; Zheng Y; Zhang G; Mai H; Han Y; Yang L; Guo S
    J Surg Res; 2010 May; 160(2):315-24. PubMed ID: 19524257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of stem cell transplantation on immunosuppression in living donor renal transplantation: a clinical trial.
    Trivedi HL; Vanikar AV; Kute VB; Patel HV; Gumber MR; Shah PR; Dave SD; Trivedi VB
    Int J Organ Transplant Med; 2013; 4(4):155-62. PubMed ID: 25013669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Donor stem cell infusion after non-myeloablative conditioning for tolerance induction to HLA mismatched adult living-donor liver graft.
    Donckier V; Troisi R; Toungouz M; Colle I; Van Vlierberghe H; Jacquy C; Martiat P; Stordeur P; Zhou L; Boon N; Lambermont M; Schandené L; Van Laethem JL; Noens L; Gelin M; de Hemptinne B; Goldman M
    Transpl Immunol; 2004; 13(2):139-46. PubMed ID: 15380544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Depletion of alloreactive T cells for tolerance induction in a recipient of kidney and hematopoietic stem cell transplantations.
    Tangnararatchakit K; Tirapanich W; Anurathapan U; Tapaneya-Olarn W; Pakakasama S; Jootar S; Slavin S; Hongeng S
    Pediatr Transplant; 2012 Dec; 16(8):E342-7. PubMed ID: 22553996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perioperative Desensitization Improves Outcomes Among Crossmatch Positive Recipients of Deceased Donor Renal Transplants.
    Sharma A; King A; Kumar D; Behnke M; McDougan F; Kimball PM
    Prog Transplant; 2016 Jun; 26(2):157-61. PubMed ID: 27207404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Desensitization Before Living Donor Kidney Transplantation in Highly HLA-Sensitized Patients: A Single-Center Study.
    De Sousa-Amorim E; Revuelta I; Blasco M; Diekmann F; Cid J; Lozano M; Sánchez-Escuredo A; Martorell J; Palou E; Campistol JM; Oppenheimer F
    Transplant Proc; 2015 Oct; 47(8):2332-5. PubMed ID: 26518919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination treatment of low dose Anti-Thymocyte Globulin (ATG), Rituximab and high dose Sirolimus as induction agents in immune-conditioned recipients.
    Ravichandran P; Natrajan T; Jaganathan R
    Int Immunopharmacol; 2006 Dec; 6(13-14):1973-6. PubMed ID: 17161350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of Biopsy-Proven Acute Antibody-Mediated Rejection Using Thymoglobulin (ATG) Monotherapy and a Combination of Rituximab, Intravenous Immunoglobulin, and Plasmapheresis: Lesson Learned from Primary Experience.
    Zheng J; Xue W; Qing X; Jing X; Hou J; Tian X; Guo Q; He X; Cai J
    Clin Transpl; 2014; ():223-30. PubMed ID: 26281149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mesenchymal stromal cells and kidney transplantation: pretransplant infusion protects from graft dysfunction while fostering immunoregulation.
    Perico N; Casiraghi F; Gotti E; Introna M; Todeschini M; Cavinato RA; Capelli C; Rambaldi A; Cassis P; Rizzo P; Cortinovis M; Noris M; Remuzzi G
    Transpl Int; 2013 Sep; 26(9):867-78. PubMed ID: 23738760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Living donor kidney transplantation in patients with donor-specific HLA antibodies enabled by anti-CD20 therapy and peritransplant apheresis.
    Klein K; Süsal C; Schäfer SM; Becker LE; Beimler J; Schwenger V; Zeier M; Schemmer P; Macher-Goeppinger S; Scherer S; Opelz G; Morath C
    Atheroscler Suppl; 2013 Jan; 14(1):199-202. PubMed ID: 23357165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction therapy with autologous mesenchymal stem cells in living-related kidney transplants: a randomized controlled trial.
    Tan J; Wu W; Xu X; Liao L; Zheng F; Messinger S; Sun X; Chen J; Yang S; Cai J; Gao X; Pileggi A; Ricordi C
    JAMA; 2012 Mar; 307(11):1169-77. PubMed ID: 22436957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.